Global Esophageal Catheters Market demand is anticipated to be valued at USD 2.2 Billion in 2022, forecast to grow at a CAGR of 7.4% to be valued at USD 4.5 Billion from 2022 to 2032. The growth of the Esophageal Catheters Market is attributed to its global utilization across the Healthcare industry.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | USD 2.1 Billion |
| Expected Market Value (2022) | USD 2.2 Billion |
| Anticipated Forecast Value (2032) | USD 4.5 Billion |
| Projected Growth Rate (2022 to 2032) | 7.4% CAGR |
An Esophageal Catheter consists of pressure sensors, which is passed through the patient’s nose down the esophagus and stomach in a test named esophageal manometry. Esophageal manometry is used to measure the rhythmic muscle contractions that occur in esophagus when patient swallow is also used to measure the coordination and force of the esophageal muscles as they move food into the stomach.
Esophageal manometry may be used to help diagnose diffuse esophageal spasm, Achalasia, Scleroderma, gastroesophageal reflux disease (GERD), chest pain etc.
North America is considered to be a dominant region for the Esophageal Catheters Market, owing to the increasing prevalence of gastrointestinal diseases in the region.
The major factor that is expected to propel the growth of the Esophageal Catheters Market during the forecast period includes the growing prevalence of chronic esophageal disorders and raising R&D activities.
The major factor that is expected to drive the growth of Esophageal Catheters Market during the forecast period includes the growing prevalence of chronic esophageal disorders and raising R&D activities.
Moreover, growing surgical procedures number, increasing healthcare awareness and growing demand for minimally invasive surgeries are some other factors that are expected to accelerate the growth of the Esophageal Catheters Market during the forecast period.
Additionally, technological advancements and growing elderly populace as they are more prone to many chronic diseases are other major factors that are expected to favor the growth of esophageal catheters market globally.
The major factor that is expected to hamper the growth of the Esophageal Catheters Market during the forecast period includes stringent regulatory approvals.
Moreover, some other factors that are expected to hinder the market growth include poor availability of esophageal catheters in emerging nations, and the high cost of the devices.
North America is the largest market for esophageal catheters, owing to the factors such as the increasing prevalence of gastrointestinal diseases, favorable reimbursement policies, the aging population, and the presence of major market players in the region.
There is a rising prevalence of GERD across the world, although there are marked differences in the reported prevalence, ranging from 14% to 26% in North America. However, it can be correlated with the rising prevalence of obesity, along with other dietary factors, in many countries.Additionally, North America Esophageal Catheters Market is expected to expand at a 6% CAGR during the forecast period.
According to Future Market Insights, Europe is anticipated to witness growth at a lucrative rate over the forecast period, owing to the increasing population as well as increasing prevalence of esophageal diseases in the region.
Moreover, the region is also expected to show a large revenue share in the global esophageal catheters market, attributed to the increasing healthcare awareness.
Some of the key participants present in the global Esophageal Catheters Market include CooperSurgical, Inc., Pennine Healthcare, EB Neuro S.p.A., PanMed US, Boston Scientific Corporation, Medtronic, and PENTAX Medical, among others.
Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as CooperSurgical, Inc., and Pennine Healthcare account for a considerable market size, several regional level players are also operating across key growth regions, particularly in the North America.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, End User, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Poland, Russia, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | CooperSurgical, Inc.; Pennine Healthcare; EB Neuro S.p.A.; PanMed Us; Boston Scientific Corporation; Medtronic; PENTAX Medical |
| Customization | Available Upon Request |
FMI projects the global Esophageal Catheters Market to expand at a 7.4% value CAGR by 2032
North America is expected to be the most opportunistic Esophageal Catheters Market, expanding at a 6% CAGR
CooperSurgical, Inc., Pennine Healthcare, EB Neuro S.p.A., PanMed Us, Boston Scientific Corporation, Medtronic, and PENTAX Medical, among others are some prominent esophageal catheters Market players
Explore Similar Insights
Esophageal Catheters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
